These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
178 related articles for article (PubMed ID: 17910836)
21. Clinical impact of correlative [123I]-FP-CIT brain imaging and neurological findings in suspect Parkinson's disease. Covelli EM; Brunetti A; Di Lauro A; Sullo P; Mazzarella G; Tedeschi E; Belfiore G Radiol Med; 2004 Oct; 108(4):417-25. PubMed ID: 15525895 [TBL] [Abstract][Full Text] [Related]
22. Correlation between neuromelanin-sensitive MR imaging and (123)I-FP-CIT SPECT in patients with parkinsonism. Kuya K; Shinohara Y; Miyoshi F; Fujii S; Tanabe Y; Ogawa T Neuroradiology; 2016 Apr; 58(4):351-6. PubMed ID: 26779912 [TBL] [Abstract][Full Text] [Related]
23. Imaging of dopamine transporters with iodine-123-FP-CIT SPECT in healthy controls and patients with Parkinson's disease. Booij J; Habraken JB; Bergmans P; Tissingh G; Winogrodzka A; Wolters EC; Janssen AG; Stoof JC; van Royen EA J Nucl Med; 1998 Nov; 39(11):1879-84. PubMed ID: 9829575 [TBL] [Abstract][Full Text] [Related]
24. FP-CIT SPECT in clinically inconclusive Parkinsonian syndrome during amiodarone treatment: a study with follow-up. Hambÿe AS; Vervaet A; Dethy S Nucl Med Commun; 2010 Jun; 31(6):583-9. PubMed ID: 20429096 [TBL] [Abstract][Full Text] [Related]
32. Diagnostic value of 123I-ioflupane and 123I-iodobenzamide SPECT scans in 248 patients with parkinsonian syndromes. Vlaar AM; de Nijs T; Kessels AG; Vreeling FW; Winogrodzka A; Mess WH; Tromp SC; van Kroonenburgh MJ; Weber WE Eur Neurol; 2008; 59(5):258-66. PubMed ID: 18264015 [TBL] [Abstract][Full Text] [Related]
33. Utility of Follow-up Dopamine Transporter SPECT With 123I-FP-CIT in the Diagnostic Workup of Patients With Clinically Uncertain Parkinsonian Syndrome. Apostolova I; Taleb DS; Lipp A; Galazky I; Kupitz D; Lange C; Makowski MR; Brenner W; Amthauer H; Plotkin M; Buchert R Clin Nucl Med; 2017 Aug; 42(8):589-594. PubMed ID: 28574876 [TBL] [Abstract][Full Text] [Related]
34. Brain parenchyma sonography and 123I-FP-CIT SPECT in Parkinson's disease and essential tremor. Doepp F; Plotkin M; Siegel L; Kivi A; Gruber D; Lobsien E; Kupsch A; Schreiber SJ Mov Disord; 2008 Feb; 23(3):405-10. PubMed ID: 18067184 [TBL] [Abstract][Full Text] [Related]
35. The cost effectiveness of 123I-FP-CIT SPECT imaging in patients with an uncertain clinical diagnosis of parkinsonism. Van Laere K; Everaert L; Annemans L; Gonce M; Vandenberghe W; Vander Borght T Eur J Nucl Med Mol Imaging; 2008 Jul; 35(7):1367-76. PubMed ID: 18385998 [TBL] [Abstract][Full Text] [Related]
37. Combined visual and semi-quantitative assessment of Ueda J; Yoshimura H; Shimizu K; Hino M; Kohara N Neurol Sci; 2017 Jul; 38(7):1187-1191. PubMed ID: 28389938 [TBL] [Abstract][Full Text] [Related]
38. Semiquantitative analysis using standardized uptake value in Toriihara A; Daisaki H; Yamaguchi A; Kobayashi M; Furukawa S; Yoshida K; Isogai J; Tateishi U Clin Imaging; 2018; 52():57-61. PubMed ID: 29909364 [TBL] [Abstract][Full Text] [Related]
39. Creation and validation of an I-123 FP-CIT template for statistical image analysis using high-resolution SPECT for parkinsonian patients. Hida K; Nonokuma M; Kuwabara Y; Tani T; Takano K; Yoshimitsu K Ann Nucl Med; 2016 Aug; 30(7):477-83. PubMed ID: 27225162 [TBL] [Abstract][Full Text] [Related]
40. Iodine-123 metaiodobenzylguanidine scintigraphy and iodine-123 ioflupane single photon emission computed tomography in Lewy body diseases: complementary or alternative techniques? Treglia G; Cason E; Cortelli P; Gabellini A; Liguori R; Bagnato A; Giordano A; Fagioli G J Neuroimaging; 2014; 24(2):149-54. PubMed ID: 23163913 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]